US · Healthcare · Biotechnology
EPS came in at -0.58 against a street estimate of -0.16 — a miss of 262.5%.
Analysts rate NeOnc Technologies Holdings, Inc. Common Stock a strong buy (4 buy, 0 hold, 0 sell out of 4) with an average price target of $17.00.
| Fund | Stake |
|---|---|
| Cinctive Capital Management LP | 6.20% |
| Vanguard Capital Management, LLC | 1.94% |
| Bank of America Corp | 0.87% |
| Westmount Partners, LLC | 0.76% |
| BlackRock Inc | 0.69% |
| Geode Capital Management, LLC | 0.64% |
| Vanguard Fiduciary Trust Co | 0.35% |
| Morgan Stanley - Brokerage Accounts | 0.20% |
Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for NeOnc Technologies Holdings, Inc. Common Stock — free to start.
Open in the appGoogle PlayApp StoreData updated 2026-10-18.